Oncotarget cover image

HER3: A Vital Target in Cancer Treatment

Oncotarget

CHAPTER

HER3 Overactivation as a Resistance Mechanism in Cancer Cells

This chapter explores how HER3 overactivation can serve as a resistance mechanism in cancer cells, potentially leading to the overexpression of EGFR or HER2. The speakers emphasize the need for further research on alternative activation mechanisms and the development of combination therapies to combat resistance.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner